The Florida-based biopharmaceutical company offers STAR Fusion and Multimer Reagents for diagnosing and targeting cancer and viral infections, as well as a monoclonal antibody that prevents and treats staphylococcal infections in premature neonates. Its products are used in direct and quantitative detection of endogenous peptide antigens' presentation on diseased cells and tissues. Altor BioScience's immunotherapies focus on the immunostimulatory properties of the cytokines IL-15 and IL-2, inducing the activation, proliferation and persistence of NK and T cells that are critical in the body's defense against cancer and infection.